The Food and Drug Administration issued updated cybersecurity guidance for medical devices, setting stricter requirements that many existing systems — and the software that runs them — cannot meet without significant redesign.
The new framework requires manufacturers to implement security throughout the product lifecycle, including documenting software components, managing vulnerabilities and maintaining secure development processes.
Today, with connected devices generating vast volumes of clinical data and playing a central role in diagnosis and treatment, securing them has become essential not only for data protection but also for ensuring care delivery itself.
The new FDA cybersecurity guidance reflects growing concern that vulnerable devices pose not just technical risks but direct threats to clinical operations and patient safety, particularly as hospitals rely on increasingly connected technologies for monitoring, diagnosis and treatment.
【MORE】